The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
10,876
Sort by:
Gaucher Disease - Drugs in Development, 2021
US$ 2,000.00
Gaucher Disease - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gaucher Disease - Drugs In Development, 2021, provides an overv...
November 2021
143 pages
Hypertension (Cardiovascular) - Drugs in Development, 2021
US$ 2,500.00
Hypertension (Cardiovascular) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hypertension - Drugs In Development, 2021, provid...
November 2021
872 pages
Keloids (Dermatology) - Drugs in Development, 2021
US$ 2,000.00
Keloids (Dermatology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Keloids - Drugs In Development, 2021, provides an overvie...
November 2021
51 pages
Macular Edema (Ophthalmology) - Drugs in Development, 2021
US$ 2,000.00
Macular Edema (Ophthalmology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Macular Edema - Drugs In Development, 2021, provi...
November 2021
102 pages
Melanoma (Oncology) - Drugs in Development, 2021
US$ 2,500.00
Melanoma (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Melanoma - Drugs In Development, 2021, provides an overview...
November 2021
4610 pages
P2X Purinoceptor 3 (P2RX3) - Drugs in Development, 2021
US$ 3,500.00
P2X Purinoceptor 3 (P2RX3) - Drugs in Development, 2021 SUMMARY P2X Purinoceptor 3 (P2RX3) - P2X purinoceptor 3 is a protein encoded by the P2RX3 gene. It belongs to the family of purinoceptors. This...
November 2021
70 pages
Prostate Cancer (Oncology) - Drugs in Development, 2021
US$ 2,500.00
Prostate Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Prostate Cancer - Drugs In Development, 2021, provid...
November 2021
4131 pages
Radiodermatitis - Drugs in Development, 2021
US$ 2,000.00
Radiodermatitis - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Radiodermatitis - Drugs In Development, 2021, provides an overv...
November 2021
73 pages
Usher Syndrome - Drugs in Development, 2021
US$ 2,000.00
Usher Syndrome - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Usher Syndrome - Drugs In Development, 2021, provides an overvie...
November 2021
82 pages
Wilson Disease - Drugs in Development, 2021
US$ 2,000.00
Wilson Disease - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Wilson Disease - Drugs In Development, 2021, provides an overvie...
November 2021
69 pages
Wounds (Dermatology) - Drugs in Development, 2021
US$ 2,500.00
Wounds (Dermatology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Wounds - Drugs In Development, 2021, provides an overview...
November 2021
274 pages
Antifungal Drugs: Technologies and Global Markets
US$ 5,500.00
This antifungal drugs report by BCC Research analyzes the global human antifungal market and assess its growth potential over the five-year period from 2016 to 2021.
November 2021
295 pages
Cervical Cancer (Oncology) - Drugs in Development, 2021
US$ 2,500.00
Cervical Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cervical Cancer - Drugs In Development, 2021, provid...
October 2021
2171 pages
